Drug recall
Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe…
FDA recall event 91972 · Class III · Pine Pharmaceuticals, LLC
Key facts
| Event ID | 91972 |
|---|---|
| Recall numbers | D-0531-2023 |
| Recalling firm | Pine Pharmaceuticals, LLC |
| Product type | Drugs |
| Products | Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled poly envelopes (primary packaging). Repackaged by Pine… |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect. |
| Initiation date | Mar 27, 2023 |
| Report date | Apr 19, 2023 |
| Termination date | Jun 1, 2023 |
| City | Tonawanda |
| State | NY |
| Country | United States |
| FEI number | 3010943533 |
At a glance
- 1–9 Products in this recall
- 1–9 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: